Epiminder Limited (ASX:EPI)

Market Cap	82.21M
Revenue (ttm)	648.18K -87.5%
Net Income	-38.14M
EPS	-0.44
Shares Out	216.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,252
Open	0.3800
Previous Close	0.3800
Day's Range	0.3750 - 0.3900
52-Week Range	0.3500 - 1.4900
Beta	n/a
Analysts	Buy
Price Target	2.20 (+478.95%)
Earnings Date	Aug 31, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EPI

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for EPI stock is "Buy." The 12-month stock price target is $2.20, which is an increase of 478.95% from the latest price.

Price Target

$2.20

(478.95% upside)

Analyst Consensus: Buy